Literature DB >> 29055453

Response to: S. Sega-Jazbec et al.: "Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis" Multiple Sclerosis and Related Disorders 2017.

Katja Thomas1, Tjalf Ziemssen2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29055453     DOI: 10.1016/j.msard.2017.08.001

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  1 in total

1.  Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Angel Chinea; William David Honeycutt; Tamara Miller; Donna Graves; Alan Jacobs; Junlong Wu; Christopher C LaGanke
Journal:  Int J MS Care       Date:  2020 Mar-Apr
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.